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Abstract
Background: PCI has been done traditionally through transfemoral route. But now transradial and transbrachial
routes are also coming up in practice. We compared transradial versus transfemoral routes for ease of operability,
time for procedure, complications, and failure rates through a prospective study.
Methods: Four hundred Patients admitted in department of cardiology for percutaneous interventions were
enrolled in the study. 200 patients were assigned to each group randomly. A single team did all the procedures.
Pre procedure, intra procedure and post procedure data of all the patients was collected, tabulated and analysed
properly.
Results: Access time (6.0 ± 1vs 4.2 ± 0.7; P =0.001); Fluoroscopy time and overall procedure time (29 ± 11.3 Vs. 27.3 ±
12.4 min) were more with trans radial than transfemoral route, respectively. The most common post procedure
complication, ecchymosis was seen in 20.5% in transfemoral group compared to 12.5% in transradial group (P 0.031).
Thrombophelibites (17.5 VS 8%, P0.004); Hematoma (14.5 Vs 0%, P 0.005); post procedure access bleed (7 VS 3%, P 0.
039) were seen in transfemoral than transradial group, respectively. Failure rates were almost similar. None of our
patients had post procedure myocardial infarction, stroke, acute renal failure and infections.
Conclusion: Transradial approach of PCI is better than transfemoral route with respect to complications like bleeding,
haematoma formation, thrombophelebites and ecchymosis is concerned. However access and fluoroscopic time is
more with the former. We recommend the transradial route for PCI.
Trial registration: Trial is retrospectively registered in ClinicalTrials.gov with the Identifier: NCT02983721, Date of
registration is December 2, 2016.
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Background
Coronary artery disease has had high morbidity and
mortality for a long time. To date percutaneous coron-
ary angiography and percutaneous transluminal coron-
ary angioplasty are standard diagnostic and therapeutic
strategy for coronary artery disease respectively [1]. The
common femoral artery has long been the access site for
doing coronary angiography and angioplasty. Femoral
artery has been the preferred site of access because of
the larger size and the larger diagnostic and angioplasty
guiding catheters being used lately. The profile of bal-
loons used is an additional factor for the same. The use
of better coronary hardware and development of newer
anticoagulants has significantly increased the spectrum
for interventions. Vascular access site bleeding is one of
the most feared complications particularly with the use
of anticoagulants and platelet glycoprotein inhibitors [2].
Percutaneous coronary intervention (PCI) can be per-
formed by the following three routes: femoral, brachial or
radial arteries. The vascular or bleeding risk associated
with the femoral approach is reported upto 10% in some
studies [2, 3]. Other complications include hematomas
accompanied by significant blood loss, arterial pseudo
aneurysms and arteriovenous fistulas. The transradial
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approach for coronary procedures is gaining fast accept-
ance. It was first introduced by Compeau [2] in 1989 for
diagnostic coronary angiography and it was subsequently
improved upon by by Kiemenji and Laarman [3] for per-
cutaneous transluminal coronary angioplasty and stenting.
The interest in the transradial approach is increasing due
to decreased associated vascular complications, conveni-
ence for the patients, earlier discharge, shorter stay in the
hospital and early ambulation [4–7]. Not only is it a safer
technique, but it is also characterized by its high success
rate, close to 90% in some populations [8]. Vascular com-
plications are lesser in the transradial approach because of
favourable anatomy, smaller size of the sheaths used and
rapid hemostasis. The main complications for the ap-
proach are smaller radial artery that may not be accessed
successfully and arterial occlusion post procedure. Radial
artery is smaller in the Asian populations compared to
West [9, 10]. Bleeding complications are lesser and easily
controllable with the radial approach because of the easy
compressibility of the radial artery. Another advantage is
that no big nerves or veins are located in the vicinity of
the artery making injury to such structures less likely. Also
there are economic benefits to the approach as reflected
by reduced hospital expenditures. Patients overwhelm-
ingly prefer the transradial over the femoral approach
[10, 11]. Although transradial approach has a lot of
benefits, it has a longer learning curve for the oper-
ator making it more challenging. It also limits the de-
vices which are used in interventions like temporary
pacemakers, intra-aortic balloon pumps and larger
devices for coronary interventions. Also it may not al-
ways be the best choice in some patients who may
have an anomalous palmer arch not providing suffi-
cient blood supply to the hand in case of occlusion of
radial artery. Due to this reason several authors recom-
mend assessment of adequacy of collateral blood flow
from the ulnar artery using Allen’s test before performing
the procedure. Entry site failure is also one of the compli-
cations [12, 13]. Vascular access site preference is thus a
choice in centers based on tradition and expertise [5]. We
at our hospital did a comprehensive prospective study on
this topic. The purpose of this study was to assess and
compare the feasibility, success and safety of Transradial
approach (TRA) verses Transfemoral approach (TFA) for
diagnostic and therapeutic coronary angiography and
coronary interventions.
Methods
This study was conducted in the tertiary care hospital
Sher-i- Kashmir Institute of Medical sciences Srinagar
(SKIMS) in the department of Cardiology. It was a
prospective study. We enrolled 400 patients, 200
patients for Transfemoral and 200 for Transradial
diagnostic coronary angiography and therapeutic
coronary interventions. Patients were randomly allocated
to either group using simple randomization with odd se-
rials going into one arm and even in to another. Patients
who had any of the exclusion criteria mentioned below
were not included in the study.
This study included patients taken for primary PCI,
elective diagnostic coronary study and elective angio-
plasties. Transradial access was performed only if modi-
fied Allen’s test was normal (Positive), suggesting the
presence of adequate collateral circulation from the
ulnar artery. Adjuvant glycoprotein IIb/IIIa inhibitors
were used wherever needed. Patients with impaired renal
function tests, lack of informed consent, severe sepsis,
local site infection, previous contrast allergy, severe intrin-
sic/iatrogenic coagulopathy (INR > 2) were excluded from
the study. Exclusion Criteria for transradial route included
an abnormal modified Allen’s test. Exclusion Criteria for
transfemoral route included peripheral vascular disease
(Iliofemoral disease).
Primary outcome measures included adverse events like
bleeding, access site, and non access site complications.
Also hospital stay duration and time of doing procedure
were used. TIMI major bleeds were defined as intracranial
or >5 g/dl in hemoglobin or a hematocrit drop of 15%.
TIMI minor bleeds were observed blood loss with a >3 g/
dl drop in hemoglobin or a 10% decrease in hematocrit or
no observed blood loss with a >4 g/dl or a drop by >12%
in hematocrit. Access site complications included surgical
repair or intervention on the access site, pseudoaneurysm
treated conservatively, or a large hematoma (documented
as >5 cm). Nonaccess site complications included coron-
ary artery dissection, acute myocardial infarction, coronary
perforation, transient ischemic attack or cerebrovascular
accident, and death during the index hospitalization.
Procedural failure was defined as a combined endpoint of
access site crossover, failed coronary angiography, or failed
target vessel revascularization, was also assessed. Patient
radiation exposure was estimated by total fluoroscopy
time. Secondary end points were other lesser common
events like sepsis, thrombophelebites, embolization etc.
Sample size calculation was done using the method given
by Sugimoto [14].
Our preference was to use the right radial and right
femoral routes as they are nearest to operator while
facing cardiac monitors, in our hospital. For the radial
approach, the wrist was sterilized and draped in usual
fashion. Hyperextension over an arm board was done
and skin over the puncture site was anesthetized with 2 –
3 ml of 1% lignocaine. A small scaled incision was per-
formed 1 cm proximal to styloid process of radius where
arterial pulse was best felt. The radial artery was punc-
tured with a 21 G needle and 6 F sheath (Cardis, Terumo)
were introduced into the artery, using Seldinger tech-
nique. All patients received verapamil (5 mg) to reduce
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radial artery spasm. Heparin (weight adjusted) was used
only in PCIs to prevent artery occlusion and not in elect-
ive diagnostic coronary studies. Long 0.038 Terumo guide
wire was used under fluoroscopic guidance. The catheter
used for transradial approach were specially designed for
transradial route such as Tiger catheter (Terumo) sized
6 F. Similarly in case of transfemoral approach our prefer-
ence was to use right femoral route. The groin was pre-
pared and draped and the site was punctured for femoral
access after anesthetizing the skin with 2–4 ml of 1% lig-
nocaine. Once the femoral puncture was done 6 F sheath
of Cordis variety was introduced and 6 F Judkins, catheter
was introduced and it was guided under fluoroscopic
guidance through the aortic route. All the patients under-
going this procedure received injection heparin (weight
adjusted). Procedural time was calculated separately. Once
the procedure was completed the radial sheath was
removed in the lab and pressure over the site was applied
for 2 h. Manual compression was used for hemostasis with
two trained medical assistants performing the compres-
sion. No vascular closure devices were used. Patients were
transferred back to the ward, where the radial site and
femoral site were clearly monitored for bleeding and other
complications. All the procedures were performed by a
single team headed by one operator in order to reduce
operator bias. Those patients where we failed to gain
radial artery access; procedure was crossed over to femoral
route and for the same reason groin was kept prepared.
Statistical analysis was done on an MS Windows-based
PC computer. The data were first keyed into a Microsoft
Excel spreadsheet and then analyzed by Statistical Package
for the Social Sciences (SPSS), Version 20.0, from SPSS
incorporation Chicago IL. We used mean, standard
deviation/standard error of mean, and percentage when
appropriate for the patient’s characteristic description.
Group differences were compared using the Pearson
χ2 or Fisher's exact test for categorical variables, or
the Student t test or the Mann–Whitney U test for
continuous variables. P-values of 0.05 or less were
considered statistically significant.
Results
A total of 400 patients were enrolled in this prospective
comparative study over a period of 2 years and 2 months
from September 2013 to November 2015 (200 patients
in transradial approach group and 200 in transfemoral
approach group). Table 1 shows the gender distribution,
smoking habits, dwelling and body mass index with
respect to each group (transradial or transfemoral). None
of the patients had undergone a previous PERCUTAN-
EOUS TRANSLUMINAL CORONARY ANGIOPLASTY.
Table 2 shows the procedure characteristics of studied
subjects. The commonest single vessel involved was left
circumflex (LCX) (15% in transfemoral group VS 11.7% in
transradial group). LAD+RCA (left anterior descending +
right coronary artery) disease was common in transfemoral
group and LCX+RCA disease was commonly picked in
transradial group. Double vessel disease was commonly
seen in both the studied arms. In transradial group 102
(51%) patients underwent PCI plus stenting, 30 (15%)
patients underwent rescue PCI plus stenting, 68 (34%)
patients underwent double vessel stenting. In transfemoral
group 118 (59%) patients underwent PCI + Stenting, 25
(12.5%) underwent rescue PCI+ Stenting, and the double
vessel stenting was done in 57 (28.5%) patients.
Table 3 and Fig. 1 show the comparison for complications
in the two groups.
Table 1 Demographic characteristics of the studied subjects
Variable Radial Femoral p value
N % N %
Gender Male 148 (74%) 134 67.0 0.279 (NS)
Female 52 (26%) 66 33.0
Dwelling Rural 114 (57%) 112 62.0 0.472 (NS)
Urban 68 (43.0%) 76 38.0
Smoking History 160 (80%) 144 (77%) 0.607
Body Mass Index (Kg/m2) mean ± SD 27.1 ± 2.4 26.9 ± 1.6 0.665 (NS)
Age, Years mean ± SD 61.8 ± 6.6 60.6 ± 10.0 0.31 (NS)
≤50 16 8 38 19
51 to 60 78 39 36 18
61 to 70 88 44 102 51
There were 148 males (74%) and 52 females (26%) in the transradial group and there were 134 (67%) males and 66 (33%) females in the transfemoral group. Both
in transradial and transfemoral group rural populace outnumbered the urban dwellers. Most of the studied subjects were smokers. The mean BMI (body mass
index) of (27.1 ± 2.4) and (26.9 ± 1.6) were observed in transradial and transfemoral group of studied subjects respectively. Most of our studied subjects were in
the age group of 51 to 70 years in both the arms
Abbreviations: N number, NS not significant, SD Standard Deviation
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Discussion
We performed therapeutic procedures like primary
percutaneous coronary intervention (PCI), rescue PCI
and elective stenting for Coronary artery diseases
(CAD). Transradial approach via right radial artery was
performed in 200 patients (148 males and 52 females)
likewise transfemoral approach via right femoral artery
was used in 200 patients (134 males and 66 females).
The mean age of the patients in the transradial approach
group was 61.8 ± 6.6 years and 60.6 ± 10 years was in
transfemoral approach. Most of the patients in both the
studied arms were in the age group of 51 to 70 years.
This reiterates the fact that age is an important risk
factor for CAD. The purpose to undertake this study
was to assess and compare the feasibility, safety and
success between the two approaches. The end result was
to look for the access time, total procedure and total
fluoroscopic time, procedure failure rate, complications
associated with the procedures and total hospital stay in
days in either of the procedures. In our study we found
that the access time was more with the transradial
approach compared to transfemoral approach (6.0 ±
1.8 min versus 4.2 ± 0.70 min, p value of <0.0001). The
total procedure time was also more in transradial ap-
proach group compared to transfemoral approach group
(29 ± 11.3 min versus 27.3 ± 12.4 min, p value of 0.03).
Similarly the total fluoroscopic time was more in trans-
radial approach compared to transfemoral approach
(6.4 ± 2.9 min versus 6.0 ± 2.5 min p value 0.015). Simi-
lar results were found in the study conducted by
Saleem Kassman et al. [15]. Ferdinand Kiemeneij et al.
[16] also showed similar results in relation to procedure
time and fluoroscopic time. Our results in terms of
access time in two approaches were similar to the
results shown in the study by Veli Vefali et al. [17] and
to a meta-analysis on 12 trials [18]. The higher time
requirements for the procedure in transradial group is
usually due to radial artery spasm (can be prevented by
using vasodilators), presence of tortuous subclavian ar-
teries in many patients (causing obstacles in advancing
the catheters), abnormal radial artery anatomy and op-
erator dependent. In our study crossover from radial to
femoral approach was required in 4% patients. Saleem
Kassman et al. [15] in their study had crossover from
radial to femoral route required in up to 4% as well.
Similarly Ferdinand Kiemeneij et al. [16] in their study
found that access failure was more common with trans-
radial procedure. The failed attempts in transradial
group are usually due to radial artery puncture failure,
radial artery spasm, the size of the catheter used, type
of procedure being done (diagnostic vs. therapeutic,
which also affects the size of catheter used), tortuosity
of the innominate trunk, dilatation of the ascending
aorta, lusoria artery and inability to track the catheter
in the left main coronary artery. Procedural success has
also been shown to be higher in trans-femoral PCI in
an updated report from the US national cardiovascular
data registry as well [19]. In the RIVAL trial, radial and
femoral approaches were both found to be safe and
effective for PCI but lower rate of local vascular com-
plications were seen in the radial approach [20].
In our study we found that post procedure complica-
tions were more common in the trans-femoral approach
group compared to transradial group. The common
complications were puncture site ecchymosis in 20.5% in
transfemoral group compared to only 12.5% in transfe-
moral group (p < 0.05). Hematomas were seen in 14.5%
of trans-femorals compared to none in the radial group.
Thrombophelibites was more common in the transfe-
moral group (17.5%) compared to only (8%) in transra-
dial group with p < 0.05. Bleeding complications were
also seen in a significantly higher number of patients in
the TFA compared to TRA. Also the TFA group had a
higher number of more severe bleeding episodes. R.
Table 2 Showing procedure characteristics of studied subjects
Radial Femoral p value
N % N %
Type of case Emergency 23 (11.5%) 31 (15.5%) 0.242 (NS)
Elective 177 (88.5%) 169 (84.5%)
Access time (min) 6.0 ± 1.8 (3, 10) 4.2 ± 0.7 (3, 5) <0.0001 (Sig)
Fluoroscopy time (min) 6.4 ± 2.9 (3, 15) 6.0 ± 2.5 (3, 15) 0.015 (sig)
Procedure time (min) 29.0 ± 11.3 (12, 60) 27.3 ± 12.4 (12, 60) 0.03 (sig)
Crossover to femoral 8 (4%) 0 0.97 (NS)
Hospital Stay (days), Mean ± SD 3.6 ± 1.3 4.0 ± 1.1 0.009 (sig)
The site of access was right radial and right femoral respectively in the transradial and transfemoral group of patients. Most of the patients were electively
selected. Access time was more in transradial group compared to transfemoral group of patients (6.0 ± 1.8 vs 4.2 ± 0.7 min) and it was statistically significant. The
fluoroscopy time was more in transradial group compared to transfemoral group and the overall procedure time was also more in transradial group (29 ± 11.3 VS
27.3 ± 12.4 min). The mean hospital stay was 3.6 ± 1.3 days (with the range of 2 to 6 days) in the transradial group compared to 4.0 ± 1.1 days (with the range of 2
to 6 days) in transfemoral group of patients which was statistically significant
Abbreviations: N number, NS not significant, sig significant, SD standard deviation
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Choussatet al [21] in their study found that access site
bleeding was seen in 7.4% in transfemoral [TFA] group
where as none had hematoma formation in transradial
[TRA] group [p = 0.04]. Agostoniet al [8] in their study
found that TRA was associated with a significantly lower
rate of complication, even at the cost of higher rate of
procedure failure and the results were consistent with
our study. Similarly Kassman et al. [15] in their study
found that radial access was associated with low rate of
access site related major bleeding (p = 0.04). Vefali et al.
[17] in their study found that only minor complications
were seen during transradial approach most commonly
being pain ecchymosis. 5.4% developed hematoma at the
access site in the transfemoral group and the results of
our study were comparable with the above study. Bleeding
complications were also significantly higher in the updated
report from the US national cardiovascular data registry
[19]. Major trials conducted for comparison of the two
procedures showed similar conclusions. In the RIFLE-
STEACS trial; a multicenter, randomized, parallel-group
study, it was found that radial access in patients with
ST-segment elevation acute coronary syndrome was
associated with significant clinical benefits, in terms of
both lower morbidity and cardiac mortality. Thus, it
should become the recommended approach in these pa-
tients, provided adequate operator and center expertise is
present [22]. Similarly, In the MATRIX access the authors
demonstrated that in patients with non-ST-segment
elevation acute coronary syndrome undergoing PCI,
radial access was associated with significant reduction
in major bleeding (OR 0.52, p 0.0002), access-site
bleeding (OR 0.41, p 0.007), and need for blood transfu-
sions (OR 0.61, p 0.02). Furthermore, the 1-year
mortality was significantly lower in radial approach
(OR 0.72, p 0.02) [23]. Thus the evidence points that
trans-radial approach has significant clinical benefits
than trans-femoral approach. In addition a study con-
ducted on 203 patients undergoing TRA who had nor-
mal, intermediate, and abnormal Allen test results
found safety and feasibility of TRA across the whole
spectrum of Allen test results thus pointing to the safety
of TRA even in patients with abnormal Allen tests [24].
Also, new evidence suggests that PCI with 7 F guiding
catheter is feasible and safe [25].
Table 3 Comparison of complications in the studied subjects
Variable Radial Femoral p value
N (%) N (%)
Hematoma 0 29 (14.5%) 0.005 (Sig)
Bleeding complications 6 (3%) 14 (7%) 0.039 (sig)
TIMI major bleeding 0 8 (4%)
TIMI minor bleeding 6 (3%) 4 (2%)
Required Blood transfusion 0 2 (1%)
Access site complications 0 10 (5%) 0.0003 (sig.)
Access site surgery/intervention 0 1 (2%) 0.63 (NS)
Thrombophlebitis 16 (8%) 35 (17.5%) 0.004 (Sig)
Pseudoaneurysm 0 2 (1%) 1.87 (NS)
Hematoma >5 cm 0 3 (1.5%) 0.002 (sig.)
Coronary perforation 0 1 (0.5%) 2.32 (NS)
Coronary dissection 0 1 (0.5%) 2.31 (NS)
Ecchymosis 25 (12.5%) 41 (20.5%) 0.031 (Sig)
Thrombosis of vessel 1 (0.5%) 0 1.000 (NS)
Access Failure 4 (2%) 0 0.082 (NS)
Sepsis 0 0 1.000 (NS)
Acute Renal injury 0 0 1.000 (NS)
Myocardial infarction 0 0 1.000 (NS)
Stroke 0 0 1.000 (NS)
Procedure failure 8 (4.0%) 0 <0.0001 (Sig)
Infective complications 0 0 1.000 (NS)
Death during hospitalization 0 1 (0.5%) 2.69 (NS)
The commonest post procedure complication was puncture site ecchymosis in
20.5% in transfemoral group compared to only 12.5% in transradial group
which is statistically significant. 17.5% developed thrombophelebites in
transfemoral group compared to only 8% in transradial group which is
statistically significant. Hematoma developed in 14.5% in transfemoral group
patients compared to none in transradial group which is statistically
significant. Post procedure access site bleeding was seen in 3% patients in
transradial group compared to 7% in transfemoral approach which was
statistically significant. However there was more access failure rate in
transradial group (2%) while as none had it in transfemoral group. Similarly
the procedure failure rate was 4% (2% due to access failure 2% due to
problem in guide wire hooking) in the transradial group compared to none in
transfemoral group and it was statistically significant. One patient (0.5%)
developed post procedure thrombosis of the vessel. None of our patients had
post procedure Myocardial infarction, Stroke, Acute Renal injury and infections
Abbreviations: N Number, Sig significant, NS not significant
Fig. 1 Comparison of complications in the studied subjects
between the transradial and transfemoral group
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In our study we found that the hospital stay was less
in transradial approach group compared to transfemoral
group (3.6 ± 1.3 days versus 4.0 ± 1.1 days, p = 0.009) and
it was statistically significant. Choussatet al [20] in their
study found that the total hospital stay was 5.0 ± 4.3 days
in the transradial group versus 4.9 ± 4.3 days in transfe-
moral group which was to some extent contrary to our
results. This could be due to the higher number of PCIs
done at our center each year (>1000 per year) giving
good expertise. However our results were consistent
with the study by Vefali et al. [17] and Ferdinand Kie
and also with the updated report from the US national
cardiovascular data registry [19].
Important conclusions can be drawn from our study.
Transradial approach has many potential advantages
compared to transfemoral approach. These include de-
creased access site complications, decreased bleeding,
early ambulation and shorter duration of hospital stay.
Potential disadvantages of transradial approach com-
pared to transfemoral approach include a longer learning
curve for the operator, increased access failure and
access site crossover, longer procedure, fluoroscopy time
and greater radiation exposure in non-experts and
possible lower procedure success rate in non-experts.
Transradial approach is safer as compared to transfemoral
approach because there are minimal post procedure
vascular complications. However, transradial approach is
more time consuming procedure. Overall hospital stay is
less with transradial approach compared to transfemoral
approach which is more needed in the developing
countries like our country where there is a scarcity of the
hospital beds and the recent increasing burden of coron-
ary artery disease.
Conclusion
Transradial approach of PCI is better than transfemoral
route with respect to complications like bleeding,
haematoma formation, thrombophelebites and ecchym-
osis is concerned. However access and fluoroscopic time
is more with the former. We recommend that more
emphasis should be put on rapid spread of expertise in
trans-radial approach. Trans-radial approach may soon
become the standard mode of access for PCIs and we
recommend the same in the Indian subcontinent where
we carried our study.
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